Please login to the form below

Not currently logged in
Email:
Password:

osteoarthritis drug

This page shows the latest osteoarthritis drug news and features for those working in and with pharma, biotech and healthcare.

Galapagos mid-stage trial failure raises concerns for Gilead deal

Galapagos mid-stage trial failure raises concerns for Gilead deal

Investigational osteoarthritis treatment misses primary endpoint in phase 2 study. Biotech company Galapagos has reported some disappointing results for its investigational osteoarthritis drug GLPG1972, raising doubts about the prospects of its

Latest news

More from news
Approximately 0 fully matching, plus 15 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...